Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study

BACKGROUND: Immune modulating therapies are associated with an increased risk of infections and malignancies. This is of particular concern in elderly inflammatory bowel disease patients. This study aims to compare the safety and efficacy of vedolizumab between young and elderly inflammatory bowel d...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:United European Gastroenterol J
Main Authors: Cohen, Nathaniel Aviv, Plevris, Nikolas, Kopylov, Uri, Grinman, Anna, Ungar, Bella, Yanai, Henit, Leibovitzh, Haim, Isakov, Naomi Fliss, Hirsch, Ayal, Ritter, Einat, Ron, Yulia, Shitrit, Ariella Bar-Gil, Goldin, Eran, Dotan, Iris, Horin, Shomron Ben, Lees, Charlie W, Maharshak, Nitsan
Format: Artigo
Sprog:Inglês
Udgivet: SAGE Publications 2020
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7724539/
https://ncbi.nlm.nih.gov/pubmed/32807038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640620951400
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker